GRACE 2.0 Risk Calculator for ACS
Six-Month Mortality Assessment
Fox 2006 GRACE nomogram · Cumulative mortality from hospital admission through 6 months.
This is the Fox 2006 admission-to-6-month mortality nomogram. It is not the separate post-discharge mortality model and not the GRACE in-hospital mortality model.
Point breakdown
| Predictor | Input | Points |
|---|---|---|
| Complete the required inputs to display the point breakdown. | ||
| Total GRACE score | — | |
About the six-month GRACE model
The Fox 2006 simplified GRACE nomogram estimates cumulative mortality from the time of hospital admission through six months after an acute coronary syndrome. The eight-variable Palm Pilot nomogram uses age, heart rate, systolic blood pressure, serum creatinine, Killip class, cardiac arrest at presentation, ST-segment deviation, and elevated initial cardiac enzymes/markers.
The original prospective validation reported a C-statistic of 0.81 for death using the simplified model. The original study enrolled 43,810 patients across 94 hospitals in 14 countries; the derivation cohort included 21,688 patients.
How the result is calculated
- Each continuous predictor is converted to nomogram points using the published UMass scoring functions.
- Killip class and the three binary variables contribute their published fixed points.
- The points are summed to obtain the total GRACE score.
- The six-month mortality percentage is obtained from the published UMass score-to-probability lookup table. Scores between published lookup values are linearly interpolated for this digital implementation.
Model scope
This implementation estimates all-cause mortality cumulatively from admission through six months. Do not interpret it as six-month mortality conditional on surviving to discharge. It is also not the GRACE in-hospital death model.
References
Clinical notes
Document key findings and keep a structured record for your own reference.
My notes
Review, edit, or remove notes saved in this browser.
Report an issue
Your feedback helps us improve the reliability and usability of this clinical tool.